Alex Gorsky - JOHNSON JOHNSON Insider

JOHNSON JOHNSON DL 1 -- Germany Stock  

EUR 103.85  0.000002  0.00%

Chairman of the Board, CEO

Mr. Alex Gorsky is Chairman of the Board, Chief Executive Officer of Directors of the Company. He was appointed as Chairman, Board of Directors in December 2012. He was named Chief Executive Officer, Chairman of the Executive Committee and joined the Board of Directors in April 2012. Mr. Gorsky began his Johnson Johnson career with Janssen Pharmaceutica Inc. in 1988. Over the next 15 years, he advanced through positions of increasing responsibility in sales, marketing, and management. In 2001, Mr. Gorsky was appointed President of Janssen Pharmaceutical Inc., and in 2003 he was named Company Group Chairman of the Johnson Johnson pharmaceutical business in Europe, the Middle East and Africa. Mr. Gorsky left Johnson Johnson in 2004 to join Novartis Pharmaceuticals Corporationrationration, where he served as head of the companys pharmaceutical business in North America. Mr. Gorsky returned to Johnson Johnson in 2008 as Company Group Chairman for Ethicon. In early 2009, he was appointed Worldwide Chairman of the Surgical Care Group and member of the Executive Committee. In September 2009, he was appointed Worldwide Chairman of the Medical Devices and Diagnostics Group. Mr. Gorsky became Vice Chairman of the Executive Committee in January 2011. Mr. Gorsky also serves on the boards of the Travis Manion Foundation, the Congressional Medal of Honor Foundation and the National Academy Foundation the Wharton Board of Overseers and as a member of the Business Roundtable Board of Directors and as the Chairman of its Corporationrationrate Governance Committee.
Age: 56  Chairman Since 2012      

Alex Gorsky Latest Insider Activity

Management Efficiency

Entity Summary

JOHNSON JOHNSON DL 1 (JNJ) is traded on Munich Stock Exchange in Germany. and employs 18 people.


Alex Gorsky, Chairman
William Perez, Director
Ronald Williams, Director
Jorge Mesquita, Chairman
Mary Coleman, Director
Michael Ullmann, President
Joaquin Duato, Chairman
Anne Mulcahy, Director
Mary Beckerle, Director
Joseph Wolk, President
Sandra Peterson, Chairman
Ian Davis, Director
Paulus Stoffels, Chairman, Ph.D
Mark McClellan, Director, Ph.D
Charles Prince, Director
Eugene Washington, Director
Scott Davis, Director
Dominic Caruso, President
Peter Fasolo, President
Susan Lindquist, Director
Louise Mehrotra, President

Stock Performance Indicators

Did you try this?

Run Transaction History Now

Transaction History

View history of all your transactions and understand their impact on performance
View All  Next Launch Transaction History

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.